Company / Depreciation & Amortization
Decoy Therapeutics Inc. Depreciation & Amortization History
FY2016-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$19.2K
FY2022
5-year range
$16.9K / $277.2K
FY2018-FY2022
Trend
+6.2%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Depreciation & Amortization has fluctuated over the past 7 years, ranging from $11,997 in FY2016 to $277,231 in FY2018.
Based on SEC 10-K filings.
$19,183 in FY2022 with a 5-year CAGR of -17.4%.
Improved from $127,408 to $19,183 over the past 2 years.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +4.2%
- 5-Year CAGR
- -17.4%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -17.4%, indicating a declining trend.
- In FY2022, depreciation & amortization increased 6.2% year-over-year.
- Peak depreciation & amortization was recorded in FY2018.
- Lowest depreciation & amortization in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -3.27 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | $19.2K | +6.2% |
| FY2021 | $18.1K | -85.8% |
| FY2020 | $127.4K | +651.7% |
| FY2019 | $16.9K | -93.9% |
| FY2018 | $277.2K | +455.8% |
| FY2017 | $49.9K | +315.8% |
| FY2016 | $12.0K | - |
As of FY2022 · SEC 10-K · Updated Jun 24, 2026